These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 15784656

  • 1. Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
    Jacobson PB, von Geldern TW, Ohman L, Osterland M, Wang J, Zinker B, Wilcox D, Nguyen PT, Mika A, Fung S, Fey T, Goos-Nilsson A, Grynfarb M, Barkhem T, Marsh K, Beno DW, Nga-Nguyen B, Kym PR, Link JT, Tu N, Edgerton DS, Cherrington A, Efendic S, Lane BC, Opgenorth TJ.
    J Pharmacol Exp Ther; 2005 Jul; 314(1):191-200. PubMed ID: 15784656
    [Abstract] [Full Text] [Related]

  • 2. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B, Mika A, Nguyen P, Wilcox D, Ohman L, von Geldern TW, Opgenorth T, Jacobson P.
    Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Blood glucose-lowering nuclear receptor agonists only partially normalize hepatic gene expression in db/db mice.
    Loffler M, Bilban M, Reimers M, Waldhäusl W, Stulnig TM.
    J Pharmacol Exp Ther; 2006 Feb; 316(2):797-804. PubMed ID: 16260581
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R, Sayyed SG, Doshi LS, Dixit P, Chandak PG, Dixit AV, Brahma MK, Deshmukh NJ, Gupte R, Damre A, Suthar J, Padigaru M, Sharma SD, Nemmani KV.
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [Abstract] [Full Text] [Related]

  • 10. Gene expression of mineralocorticoid and glucocorticoid receptors in the limbic system is related to type-2 like diabetes in leptin-resistant rats.
    Jöhren O, Dendorfer A, Dominiak P, Raasch W.
    Brain Res; 2007 Dec 12; 1184():160-7. PubMed ID: 17945204
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T, Farrelly D, Tieman A, Chu C, Kunselman L, Gu L, Ponticiello R, Cap M, Qu F, Shao C, Wang W, Zhang H, Fenderson W, Chen S, Devasthale P, Jeon Y, Seethala R, Yang WP, Ren J, Zhou M, Ryono D, Biller S, Mookhtiar KA, Wetterau J, Gregg R, Cheng PT, Hariharan N.
    Diabetes; 2006 Jan 12; 55(1):240-8. PubMed ID: 16380499
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.
    Diabetes Obes Metab; 2007 Nov 12; 9(6):879-88. PubMed ID: 17924870
    [Abstract] [Full Text] [Related]

  • 16. The role of the liver on post-prandial glycaemia--emphasis on hepatic glucose uptake.
    Kawamori R.
    Int J Clin Pract Suppl; 2000 Sep 12; (112):19-22. PubMed ID: 11064947
    [No Abstract] [Full Text] [Related]

  • 17. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Zuo YQ, Liu WP, Niu YF, Tian CF, Xie MJ, Chen XZ, Li L.
    J Pharm Pharmacol; 2008 Oct 12; 60(10):1335-40. PubMed ID: 18812026
    [Abstract] [Full Text] [Related]

  • 18. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG, Jung DY, Ko HJ, Zhang Z, Ma Z, Jun JY, Kim JH, Sumner AD, Vary TC, Gardner TW, Bronson SK, Kim JK.
    Am J Physiol Endocrinol Metab; 2007 Dec 12; 293(6):E1687-96. PubMed ID: 17911348
    [Abstract] [Full Text] [Related]

  • 19. Exendin-4 and exercise improve hepatic glucose homeostasis by promoting insulin signaling in diabetic rats.
    Park S, Hong SM, Ahn IS.
    Metabolism; 2010 Jan 12; 59(1):123-33. PubMed ID: 19766272
    [Abstract] [Full Text] [Related]

  • 20. Halofenate is a selective peroxisome proliferator-activated receptor gamma modulator with antidiabetic activity.
    Allen T, Zhang F, Moodie SA, Clemens LE, Smith A, Gregoire F, Bell A, Muscat GE, Gustafson TA.
    Diabetes; 2006 Sep 12; 55(9):2523-33. PubMed ID: 16936200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.